Motor effects of (−)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions-Reference-Cited by-同舟云学术

Motor effects of (−)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions

Published:2000-02 Issue:2-3 Volume:389 Page:193-199
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ekesbo Anna,Andrén Per E,Gunne Lars M,Sonesson Clas,Tedroff Joakim

Publisher

Elsevier BV

Subject

Pharmacology

Reference23 articles.

1. Behavioural analysis of unilateral monoamine depletion in the marmoset;Annett;Brain,1992

2. DOPA-induced “peak dose” dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys;Blanchet;J. Neural Transm., Suppl.,1995

3. Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-DOPA or a novel dopamine D1 receptor agonist, A68930;Britton;Eur. J. Pharmacol.,1991

4. (−)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease;Ekesbo;NeuroReport,1997

5. Effects of the substituted (S)-3-phenylpiperidine (−)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains;Ekesbo;Neuropharmacology,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dopamine receptor-related compounds on naïve common marmosets for auditory steady-state response;Journal of Neurophysiology;2022-07-01

2. Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious preclinical evaluations;Behavioural Pharmacology;2020-02

3. The dopaminergic stabilizer pridopidine decreases expression of l-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model;European Journal of Pharmacology;2013-01

4. The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties;European Journal of Pharmacology;2010-02

5. The Dopamine Stabilizers (S)-(-)-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-Methanesulfonylphenyl)-1-propyl-piperidine (ACR16) Show High in Vivo D2Receptor Occupancy, Antipsychotic-Like Efficacy, and Low Potential for Motor Side Effects in the Rat;Journal of Pharmacology and Experimental Therapeutics;2006-04-28